Shirin Dashtbin

638 total citations
20 papers, 401 citations indexed

About

Shirin Dashtbin is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Shirin Dashtbin has authored 20 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 8 papers in Epidemiology and 6 papers in Molecular Biology. Recurrent topics in Shirin Dashtbin's work include Antibiotic Use and Resistance (3 papers), COVID-19 Clinical Research Studies (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Shirin Dashtbin is often cited by papers focused on Antibiotic Use and Resistance (3 papers), COVID-19 Clinical Research Studies (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Shirin Dashtbin collaborates with scholars based in Iran and Iraq. Shirin Dashtbin's co-authors include Roya Ghanavati, Marzie Mahdizade Ari, Sima Kazemi, Ali Teimoori, Hossein Keyvani, Rasoul Mirzaei, Rasoul Yousefimashouf, Sajad Karampoor, Kamran Tari and Mehdi Salari and has published in prestigious journals such as Frontiers in Microbiology, Behavioural Brain Research and Frontiers in Pharmacology.

In The Last Decade

Shirin Dashtbin

18 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shirin Dashtbin Iran 9 185 114 70 67 39 20 401
Muhammad Ibrahim Getso Iran 12 329 1.8× 212 1.9× 52 0.7× 45 0.7× 32 0.8× 56 659
Sandra Valderrama Colombia 14 248 1.3× 230 2.0× 72 1.0× 37 0.6× 18 0.5× 49 512
Rokhsareh Mohammadzadeh Iran 12 182 1.0× 94 0.8× 70 1.0× 239 3.6× 17 0.4× 21 579
Seyed Ali Dehghan Manshadi Iran 11 286 1.5× 136 1.2× 46 0.7× 43 0.6× 12 0.3× 70 505
Shahnaz Armin Iran 13 234 1.3× 179 1.6× 63 0.9× 83 1.2× 10 0.3× 86 573
Saeed Shams Iran 9 156 0.8× 95 0.8× 156 2.2× 128 1.9× 26 0.7× 24 564
Rémi Le Guern France 14 183 1.0× 134 1.2× 57 0.8× 144 2.1× 8 0.2× 34 503
Vijaya Lakshmi Nag India 12 240 1.3× 136 1.2× 20 0.3× 33 0.5× 28 0.7× 68 430
Frieder Fuchs Germany 11 439 2.4× 320 2.8× 73 1.0× 102 1.5× 24 0.6× 31 659
Mahmoud Shorman United States 14 245 1.3× 209 1.8× 36 0.5× 48 0.7× 41 1.1× 42 504

Countries citing papers authored by Shirin Dashtbin

Since Specialization
Citations

This map shows the geographic impact of Shirin Dashtbin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shirin Dashtbin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shirin Dashtbin more than expected).

Fields of papers citing papers by Shirin Dashtbin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shirin Dashtbin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shirin Dashtbin. The network helps show where Shirin Dashtbin may publish in the future.

Co-authorship network of co-authors of Shirin Dashtbin

This figure shows the co-authorship network connecting the top 25 collaborators of Shirin Dashtbin. A scholar is included among the top collaborators of Shirin Dashtbin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shirin Dashtbin. Shirin Dashtbin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asadollahi, Parisa, et al.. (2024). Microbiome and bladder cancer: the role of probiotics in treatment. Future Microbiology. 20(1). 73–90. 4 indexed citations
2.
3.
Khosravifar, Mina, et al.. (2024). A domestic strain of Lactobacillus rhamnosus attenuates cognitive deficit and pro-inflammatory cytokine expression in an animal model of Alzheimer’s disease. Behavioural Brain Research. 476. 115277–115277. 8 indexed citations
4.
5.
Darbandi, Atieh, Milad Abdi, Shirin Dashtbin, et al.. (2024). Antibody–Antibiotic Conjugates: A Comprehensive Review on Their Therapeutic Potentials Against BacterialInfections. Journal of Clinical Laboratory Analysis. 38(10). e25071–e25071. 5 indexed citations
6.
Dashtbin, Shirin, Arezoo Asadi, Parisa Asadollahi, et al.. (2024). Prevalence of linezolid resistance in Streptococcus pneumoniae isolates: a systematic review and meta-analysis. Future Microbiology. 19(5). 449–459. 1 indexed citations
7.
Motamedi, Hamid, Ramin Abiri, Mohsen Shahlaei, et al.. (2023). Designing a novel multi-epitopes pan-vaccine against SARS-CoV-2 and seasonal influenza: in silico and immunoinformatics approach. Journal of Biomolecular Structure and Dynamics. 42(20). 10761–10784. 8 indexed citations
8.
Rostamian, Mosayeb, et al.. (2023). High burden of MDR, XDR, PDR, and MBL producing Gram negative bacteria causing infections in Kermanshah health centers during 2019-2020. Iranian Journal of Microbiology. 15(3). 359–372. 2 indexed citations
9.
Taki, Elahe, et al.. (2023). Ebanga™: The most recent FDA-approved drug for treating Ebola. Frontiers in Pharmacology. 14. 1083429–1083429. 20 indexed citations
10.
Dashtbin, Shirin, Ramin Abiri, Hamid Motamedi, et al.. (2023). Global prevalence of Clostridioides difficile in 17,148 food samples from 2009 to 2019: a systematic review and meta-analysis. Journal of Health Population and Nutrition. 42(1). 36–36. 8 indexed citations
11.
Ari, Marzie Mahdizade, et al.. (2023). Nitrofurantoin: properties and potential in treatment of urinary tract infection: a narrative review. Frontiers in Cellular and Infection Microbiology. 13. 1148603–1148603. 36 indexed citations
12.
13.
14.
15.
Heidary, Mohsen, Shirin Dashtbin, Roya Ghanavati, et al.. (2022). Evaluation of Brucellosis Vaccines: A Comprehensive Review. Frontiers in Veterinary Science. 9. 925773–925773. 40 indexed citations
16.
Akbari, Maryam, et al.. (2022). Comparison of clinical, radiological and laboratory findings in discharged and dead patients with COVID-19. Vacunas. 23. S36–S43. 5 indexed citations
17.
Dashtbin, Shirin, et al.. (2022). Investigation of drug regimens and treatment outcome in patients with Mycobacterium Simiae: a systematic review. Expert Review of Anti-infective Therapy. 20(7). 1015–1023. 1 indexed citations
18.
Heidary, Mohsen, Arezoo Asadi, Shirin Dashtbin, et al.. (2022). COVID‐19 in HIV‐positive patients: A systematic review of case reports and case series. Journal of Clinical Laboratory Analysis. 36(4). e24308–e24308. 15 indexed citations
19.
Motamedi, Hamid, et al.. (2021). An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages. International Immunopharmacology. 96. 107763–107763. 35 indexed citations
20.
Mirzaei, Rasoul, Ali Salimi Jeda, Shirin Dashtbin, et al.. (2020). Bacterial co‐infections with SARS‐CoV‐2. IUBMB Life. 72(10). 2097–2111. 206 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Muhammad Ibrahim Getso Breakdown of academic impact, for papers by Sandra Valderrama Breakdown of academic impact, for papers by Rokhsareh Mohammadzadeh Breakdown of academic impact, for papers by Seyed Ali Dehghan Manshadi Breakdown of academic impact, for papers by Shahnaz Armin Breakdown of academic impact, for papers by Saeed Shams Breakdown of academic impact, for papers by Rémi Le Guern Breakdown of academic impact, for papers by Vijaya Lakshmi Nag Breakdown of academic impact, for papers by Frieder Fuchs Breakdown of academic impact, for papers by Mahmoud Shorman
Rankless by CCL
2026